Attached files
| file | filename |
|---|---|
| EX-32 - EX-32 - Theravance Biopharma, Inc. | a2227703zex-32.htm |
| EX-31.2 - EX-31.2 - Theravance Biopharma, Inc. | a2227703zex-31_2.htm |
| EX-23.1 - EX-23.1 - Theravance Biopharma, Inc. | a2227703zex-23_1.htm |
| EX-10.6 - EX-10.6 - Theravance Biopharma, Inc. | a2227703zex-10_6.htm |
| EX-31.1 - EX-31.1 - Theravance Biopharma, Inc. | a2227703zex-31_1.htm |
| EX-10.47 - EX-10.47 - Theravance Biopharma, Inc. | a2227703zex-10_47.htm |
| EX-10.46 - EX-10.46 - Theravance Biopharma, Inc. | a2227703zex-10_46.htm |
| EX-10.48 - EX-10.48 - Theravance Biopharma, Inc. | a2227703zex-10_48.htm |
| EX-10.49 - EX-10.49 - Theravance Biopharma, Inc. | a2227703zex-10_49.htm |
| 10-K - 10-K - Theravance Biopharma, Inc. | a2227703z10-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
Theravance
Biopharma US, Inc. (Delaware)
Theravance Biopharma Antibiotics, Inc. (Cayman Islands)
Theravance Biopharma R&D, Inc. (Cayman Islands)
Theravance Biopharma UK Limited (England and Wales)
Theravance Biopharma Ireland Limited (Ireland)
Theravance Biopharma Cayman Holdings, Inc. (Cayman Islands)
Theravance Biopharma R&D IP LLC (Delaware)
Theravance Biopharma Antibiotics IP LLC (Delaware)
Subsidiaries